Forbes December 30, 2024
Mohan Kumar

Mohan Kumar, an expert in Hyper-Scalable Temporal Data, drives innovation at AtoB; formerly of LinkedIn, Zenefits and D.E. Shaw.

Startups and growing companies often face the pivotal question, “Should we build a solution in-house or buy it off the shelf?” This decision significantly impacts resources, scalability and competitive positioning.

Some companies thrive or fail based on this decision, making it one of the most critical challenges for leadership. The stakes are high: A wrong choice can lead to declining revenue, layoffs and lost market share. Conversely, the right choice can enable a company to outperform competitors, capture a larger total addressable market and solidify itself as an industry leader.

While there’s no one-size-fits-all answer, I’ll explore the strategies, key considerations...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Trends
5 Notable Health Tech Funding Announcements in February
China's Honor pledges $10 billion AI investment and deepens ties with Google in global push
BridgeBio oncology spinout to go public in blank-check merger
Zoom invests in AI startup Suki
What's next for healthcare private equity?

Share This Article